Likes
Serum Institute as we all know that it's a very good company, it provide salary without delay and give the employe a very good experience to grow in life ..
read moreCompany name | Avg Annual Salary | Open Jobs |
---|---|---|
Bharat Biotech International Associate Salary
0 - 2 years exp. (7 salaries) | ₹1.9 L/yr - ₹3.3 L/yr
32%
less | |
Cipla Associate Salary
0 - 12 years exp. (70 salaries) | ₹1.8 L/yr - ₹7 L/yr
21%
more | |
Login to view exact salary
| ||
Biocon Limited Associate Salary
0 - 17 years exp. (5 salaries) | ₹2.1 L/yr - ₹12 L/yr
91%
more | |
Sun Pharmaceutical Industries Associate Salary
0 - 10 years exp. (41 salaries) | ₹2.2 L/yr - ₹7 L/yr
1%
less | |
Zydus Lifesciences Associate Salary
1 - 9 years exp. (56 salaries) | ₹1.7 L/yr - ₹9 L/yr
19%
more | |
Piramal Group Associate Salary
0 - 5 years exp. (3 salaries) | ₹4.3 L/yr - ₹15.7 L/yr
124%
more | |
Glenmark Pharmaceuticals Associate Salary
1 - 6 years exp. (10 salaries) | ₹1.7 L/yr - ₹6 L/yr
12%
less | |
Lupin Associate Salary
1 - 7 years exp. (313 salaries) | ₹1.6 L/yr - ₹5.4 L/yr At par | |
Avantor Associate Salary
0 - 7 years exp. (127 salaries) | ₹1.8 L/yr - ₹5 L/yr
5%
more | 1 job opening |
Novozymes South Asia Associate Salary
3 - 12 years exp. (9 salaries) | ₹4 L/yr - ₹8.5 L/yr
44%
more | |
Pall Corporation Associate Salary
10 - 14 years exp. (4 salaries) | ₹15 L/yr - ₹20.2 L/yr
389%
more | |
Login to view exact salary
| ||
Biocon Biologics Associate Salary
0 - 3 years exp. (4 salaries) | ₹2 L/yr - ₹7.5 L/yr
31%
more | |
Jubilant Biosys Associate Salary
1 - 5 years exp. (3 salaries) | ₹3.8 L/yr - ₹6 L/yr
25%
more | |
LifeCell International Associate Salary
1 - 4 years exp. (3 salaries) | ₹2.4 L/yr - ₹4 L/yr
17%
less | |
Last Updated: 11 Apr 2024
Experience | Avg Annual Salary |
---|---|
2 years (AmbitionBox Estimate) |
₹2.3
L/yr
- ₹2.9
L/yr
|
3 years (AmbitionBox Estimate) |
₹4.1
L/yr
- ₹5.2
L/yr
|
Login to view exact salary
| |
5 years (AmbitionBox Estimate) |
₹3.4
L/yr
- ₹4.4
L/yr
|
Discover interview dos and don'ts from real experiences
Top trending discussions